Quest Diagnosticsvs.Hologic
DGX vs HOLX · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Quest Diagnostics is about 1.4× larger than Hologic by market cap; Quest Diagnostics trades at the lower P/E (22.6 vs 31.2); year to date, Quest Diagnostics leads (+19.5% vs +2.0%).
Side by side
| DGX | HOLX | |
|---|---|---|
| Market cap | $23.1B | $17B |
| Price | $207.44 | — |
| Today | −0.3% | — |
| Return YTD | +19.5% | +2.0% |
| Return 1Y | +21.0% | −3.5% |
| P/E | 22.6 | 31.2 |
| P/S | 2.1 | 4.1 |
| P/B | 3.1 | 3.2 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Quest DiagnosticsDGX
Nationwide clinical laboratory network for routine and advanced diagnostics.
Full DGX profile →HologicHOLX
American medical technology company focused on women's health — diagnostics, mammography (imaging) and surgery.
Full HOLX profile →More comparisons in Diagnostics
See where DGX and HOLX sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →